Substrates and supplements for hESCs: A critical review

Journal of Assisted Reproduction and Genetics

Volumn 30, Issue 3, 2013, Pages 315-323

  Crocco, Melisa Candela ^a   Fratnz, Nilo ^b   Bos Mikich, Adriana ^c  

^a Administracion Nacional de Laboratorios E Institutos de Salud Dr Carlos G Malbran   (Argentina)

^b Nilo Frantz Reserach and Human Reproduction Center   (Brazil)

^c FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Embryonic stem cells; hESC; Substrate; Supplements

Indexed keywords

ACTIVIN; COLLAGEN; FIBRONECTIN; LAMININ; LEUKEMIA INHIBITORY FACTOR; NOGGIN; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR NANOG; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; BIOREACTOR; BLASTOCYST; BONE MARROW CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; CHEMICAL COMPOSITION; CRYOPRESERVATION; CULTURE MEDIUM; EMBRYONIC STEM CELL; ENZYME SUBSTRATE; EXTRACELLULAR MATRIX; FIBROBLAST; HUMAN; HUMAN CELL CULTURE; INNER CELL MASS; NONHUMAN; PHENOTYPE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; UTERINE TUBE; ZONA PELLUCIDA;

CELL CULTURE TECHNIQUES; CELL LINE; COLLAGEN; DRUG COMBINATIONS; EMBRYONIC STEM CELLS; FEEDER CELLS; FIBROBLASTS; HUMANS; LAMININ; PROTEOGLYCANS;

ANIMALIA;

EID: 84876292483     PISSN: 10580468     EISSN: 15737330     Source Type: Journal    
DOI: 10.1007/s10815-012-9914-8     Document Type: Article

References (80)

1. Amit M, Carpenter MK, Inokuma MS, et al. Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture. Dev Biol. 2000;227:271-8.
2. Amit M, Margulets V, Segev H, et al. Human feeder layers for human embryonic stem cells. Biol Reprod. 2003;68:2150-6.
3. Arabadjiev B, Petkova R, Chakarov S, Momchilova A, Pankov R. Do we need more human embryonic stem cell lines? Biotechnol Biotechnol Equip. 2010;24(3):1921-7.
4. Armstrong L, Hughes O, Yung S, et al. The role of PI3K/AKT, MAPK/ERK and NFkappabeta signalling in the maintenance of human embryonic stem cell pluripotency and viability highlighted by transcriptional profiling and functional analysis. Hum Mol Genet. 2006;15(11):1894-913.
5. Beattie GM, Lopez AD, Bucay N, et al. Activin A maintains pluripotency of human embryonic stem cells in the absence of feeder layers. Stem Cells. 2005;23:489-95.
6. Bendall SC, Stewart MH, Menendez P, et al. IGF and FGF cooperatively establish the regulatory stem cell niche of pluripotent human cells in vitro. Nature. 2007;448:1015-21.
7. Brafman DA, Shah KD, Fellner T, Chien S, Willert K. Defining long-term maintenance conditions of human embryonic stem cells with arrayed cellular microenvironment technology. Stem Cells Dev. 2009;18(8):1141-54.
8. Brafman DA, Chang CW, Fernandez A, Willert K, Varghese S, Chien S. Long-term human pluripotent stem cell self-renewal on synthetic polymer surfaces. Biomaterials. 2010;31(34):9135-44.
9. Brimble SN, Zeng X, Weiler DA, et al. Karyotypic stability, genotyping, differentiation, feeder-free maintenance, and gene expression sampling in three human embryonic stem cell lines derived prior to August 9, 2001. Stem Cells Dev. 2004;13(6):585-97.
10. Brindley DA, Davie NL, Culme-Seymour EJ, Mason C, Smith DW, Rowley JA. Peak serum: implications of serum supply for cell therapy manufacturing. Regen Med. 2012;7(1):7-13.
11. Brook FA, Cowley SA, Evans EP, Turner K, James WS, Mardon HJ. Derivation and characterisation of the human embryonic stem cell line, OxF1. In Vitro Cell Dev Biol Anim. 2010;46:173-7.
12. Burdick JA, Vunjak-Novakovic GV. Engineered microenvironments for controlled stem cell differentiation. Tissue Eng Part A. 2009;15:205-19.
13. Camarasa MV, Kerr RW, Sneddon SF, et al. Derivation of Man-1 and Man-2 research grade human embryonic stem cell lines. In Vitro Cell Dev Biol-Animal. 2010;46:386-94.
14. Chavez SL, Meneses JJ, Nguyen HN, Kim SK, Pera RA. Characterization of six new human embryonic stem cell lines (HSF7, -8, -9, -10, -12, and -13) derived under minimal-animal component conditions. Stem Cells Dev. 2008;17(3):535-46.
15. Chen HF, Chuang CY, Shieh YK, Chang HW, Ho HN, Kuo HC. Novel autogenic feeders derived from human embryonic stem cells (hESCs) support an undifferentiated status of hESCs in xeno-free culture conditions. Hum Reprod. 2009;24(5):1114-25.
16. Chen G, Gulbranson DR, Hou Z, Bolin JM, Ruotti V, Probasco MD, et al. Chemically defined conditions for human iPSC derivation and culture. Nat Methods. 2011;8(5):424-9. doi: 10.1038/nmeth.1593.
17. Crook JM, Peura TT, Kravets L, et al. The generation of six clinical-grade human embryonic stem cell lines. Cell Stem Cell. 2007;1(5):490-4.
18. Darr H, Mayshar Y, Benvenisty N. Overexpression of NANOG in human ES cells enables feeder-free growth while inducing primitive ectoderm features. Development. 2006;133:1193-201.
19. Elefanty AG, Stanley EG. Defined substrates for pluripotent stem cells: are we there yet? Nat Methods. 2010;7:967-8.
20. Ellerstrom C, Strehl R, Moya K, et al. Derivation of a xeno-free human embryonic stem cell line. Stem Cells. 2006;24:2170-6.
21. Fletcher JM, Ferrier PM, Gardner JO, et al. Variations in humanized and defined culture conditions supporting derivation of new human embryonic stem cell lines. Cloning Stem Cells. 2006;8(4):319-34.
22. Genbacev O, Krtolica A, Zdravkovic T, et al. Serum-free derivation of human embryonic stem cell lines on human placental fibroblast feeders. Fertil Steril. 2005;83:1517-29.
23. Hakala H, Rajala K, Ojala M, et al. Comparison of biomaterials and extracellular matrices as a culture platform for multiple, independently derived human embryonic stem cell lines. Tissue Engineering Part A, 2009;1775-1785.
24. Heins N, Englund MC, Sjöblom C, et al. Derivation, characterization, and differentiation of human embryonic stem cells. Stem Cells. 2004;22(3):367-76.
25. Hovatta O, Mikkola M, Gertow K, et al. A culture system using human foreskin fibroblasts as feeder cells allows production of human embryonic stem cells. Hum Reprod. 2003;18:1404-9.
26. Ilic D, Giritharan G, Zdravkovic T, et al. Derivation of human embryonic stem cell lines from biopsied blastomeres on human feeders with minimal exposure to xenomaterials. Stem Cells Dev. 2009;18(9):1343-9.
27. Ilic D, Stephenson E, Wood V, et al. Derivation and feeder-free propagation of human embryonic stem cells under xeno-free conditions. Cytotherapy. 2012;14(1):122-8.
28. Inamdar MS, Venu P, Srinivas MS, Rao K, VijayRaghavan K. Derivation and characterization of two sibling human embryonic stem cell lines from discarded Grade III embryos. Stem Cells Dev. 2009;18(3):423-33.
29. Inzunza J, Gertow K, Stromberg MA, et al. Derivation of human embryonic stem cell lines in serum replacement medium using postnatal human fibroblasts as feeder cells. Stem Cells. 2005;23:544-9.
30. Irwin EF, Gupta R, Dashti DC, Healy KE. Engineered polymer-media interfaces for the long-term self-renewal of human embryonic stem cells. Biomaterials. 2011;32(29):6912-9.
31. Klim JR, Li L, Wrighton PJ, Piekarczyk MS, Kiessling LL. A defined glycosaminoglycan-binding substratum for human pluripotent stem cells. Nat Methods. 2010;7(12):989-94.
32. Klimanskaya I, Chung Y, Meisner L, Johnson J, West M, Lanza R. Human embryonic stem cells derived without feeder cells. Lancet. 2005;365:1636-41.
33. Klimanskaya I, Chung Y, Becker S, Lu S, Lanza R. Human embryonic stem cell lines derived from single blastomeres. Nature. 2006;444:481-5.
34. Kumar N, Hinduja I, Nagvenkar P, et al. Derivation and characterization of two genetically unique human embryonic stem cell lines on in-house-derived human feeders. Stem Cells Dev. 2009;18(3):435-45.
35. Laurent LC, Ulitsky I, Slavin I, et al. Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in cultura. Cell Stem Cell. 2011;8:106-18.
36. Lee S, Kim J, Park TJ, Shin Y, Lee SY, Han YM, et al. The effects of the physical properties of culture substrates on the growth and differentiation of human embryonic stem cells. Biomaterials. 2011;32(34):8816-29.
37. Lees JG, Lim SA, Croll T, et al. Transplantation of 3D scaffolds seeded with human embryonic stem cells: biological features of surrogate tissue and teratoma-forming potential. Regen Med. 2007;2(3):289-300.
38. Lei T, Jacob S, Ajil-Zaraa I, et al. Xeno-free derivation and culture of human embryonic stem cells: current status, problems and challenges. Cell Res. 2007;17(8):682-8.
39. Levenberg S, Huang N, Lavik E, Rogers A, Itskovitz-Eldor J, Langer R. Differentiation of human embryonic stem cells on three-dimensional polymer scaffolds. Proc Natl Acad Sci USA. 2003;100:12741-6.
40. Levenstein ME, Ludwig TE, Xu RH, et al. Basic fibroblast growth factor support of human embryonic stem cell self-renewal. Stem Cells. 2006;24(3):568-74.
41. Lim HL, Chuang JC, Tran T, Arya G, Varghese S. Dynamic electromechanical hydrogel matrices for stem cell culture. Adv Funct Mater. 2011;21:55-63.
42. Lin G, OuYang Q, Zhou X, et al. A highly homozygous and parthenogenetic human embryonic stem cell line derived from a one-pronuclear oocyte following in vitro fertilization procedure. Cell Res. 2007;17(12):999-1007.
43. Lu J, Hou R, Booth CJ, Yang S, Snyder M. Defined culture conditions of human embryonic stem cells. PNAS. 2006;103(15):5688-93.
44. Ludwig TE, Levenstein ME, Jones JM, et al. Derivation of human embryonic stem cells in defined conditions. Nat Biotechnol. 2006;24(2):185-7.
45. Mai Q, Yu Y, Li T, et al. Derivation of human embryonic stem cell lines from parthenogenetic blastocysts. Cell Res. 2007;17:1008-19.
46. Meng G, Liu S, Krawetz R, Chan M, Chernos J, Rancourt DE. A novel method for generating xeno-free human feeder cells for human embryonic stem cell culture. Stem Cells Dev. 2008;17:413-22.
47. Meng G, Liu S, Li X, Krawetz R, Rancourt DE. Extracellular matrix isolated from foreskin fibroblasts supports long-term xeno-free human embryonic stem cell culture. Stem Cells Dev. 2010;19(4):547-56.
48. Montes R, Ligero G, Sanchez L, et al. Feeder-free maintenance of hESCs in mesenchymal stem cell-conditioned media: distinct requirements for TGF-β and IGF-II. Cell Res. 2009;19:698-709.
49. Nagaoka M, Si-Tayeb K, Akaike T, Duncan SA. Culture of human pluripotent stem cells using completely defined conditions on a recombinant E-cadherin substratum. BMC Dev Biol. 2010;10:60.
50. Peiffer I, Barbet R, Zhou YP, et al. Use of xenofree matrices and molecularly-defined media to control human embryonic stem cell pluripotency: effect of low physiological TGF-beta concentrations. Stem Cells Dev. 2008;17(3):519-33.
51. Placzek MR, Chung I-M, Macedo HM, et al. Stem cell bioprocessing: fundamentals and principles. J R Soc Interface. 2009;6:209-32.
52. Priddle H, Allegrucci C, Burridge P, et al. Derivation and characterisation of the human embryonic stem cell lines, NOTT1 and NOTT2. In Vitro Cell Dev Biol - Animal. 2010;46:367-75.
53. Rajala K, Hakala H, Panula S, et al. Testing of nine different xeno-free culture media for human embryonic stem cell cultures. Hum Reprod. 2007;22(5):1231-8.
54. Rajala K, Lindroos B, Hussein SM, et al. A defined and xeno-free culture method enabling the establishment of clinical-grade human embryonic, induced pluripotent and adipose stem cells. PLoS One. 2010;5(4):e10246.
55. Raya A, Rodríguez-Pizà I, Arán B, Consiglio A, Barri PN, Veiga A, et al. Generation of cardiomyocytes from new human embryonic stem cell lines derived from poor-quality blastocysts. Cold Spring Harb Symp Quant Biol. 2008;73:127-35.
56. Richards M, Tan S, Fong CY, Biswas A, Chan WK, Bongso A. Comparative evaluation of various human feeders for prolonged undifferentiated growth of human embryonic stem cells. Stem Cells. 2003;21:546-56.
57. Riz I, Hawley RG. Genomic stability in stem cells. In: Rajasekhar VK, Vemuri MC, editors. Regulatory networks in stem cells, stem cell biology and regenerative medicine. Humana Press. 2009. p. 67-74.
58. Ruggeri RR, Watanabe Y, Meirelles F, Bressan FF, Frantz N, Bos-Mikich A. The use of parthenotegenetic and IVF bovine blastocysts as a model for the creation of human embryonic stem cells under defined conditions. J Assist Reprod Genet. 2012;29(10):1039-43.
59. Sidhu KS, Lie KH, Tuch BE. Transgenic human fetal fibroblasts as feeder layer for human embryonic stem cell lineage selection. Stem Cells Dev. 2006;15:741-7.
60. Skottman H, Hovatta O. Culture conditions for human embryonic stem cells. Reproduction. 2006;132:691-8.
61. Skottman H, Dilber MS, Hovatta O. The derivation of clinical-grade human embryonic stem cell lines. FEBS Lett. 2006;580:2875-8.
62. Spits C, Mateizel I, Geens M, et al. Recurrent chromosomal abnormalities in human embryonic stem cells. Nat Biotechnology. 2008;26:1361-3.
63. Steiner D, Khaner H, Cohen M, et al. Derivation, propagation and controlled differentiation of human embryonic stem cells in suspension. Nat Biotechnology. 2010;28(4):361-6.
64. Stojkovic P, Lako M, Stewart R, et al. An autogeneic feeder cell system that efficiently supports growth of undifferentiated human embryonic stem cells. Stem Cells. 2005;23(3):306-14.
65. Stojkovic P, Lako M, Przyborski S, et al. Human-serum matrix supports undifferentiated growth of human embryonic stem cells. Stem Cells. 2005;23(7):895-902.
66. Strelchenko N, Verlinsky O, Kukharenko V, Verlinsky Y. Morula-derived human embryonic stem cells. Reprod Biomed Online. 2004;9:623-9.
67. Ström S, Inzunza J, Grinnemo K, et al. Mechanical isolation of the inner cell mass is effective in derivation of new human embryonic stem cell lines. Hum Reprod. 2007;22(12):3051-8.
68. Sudheer S, Bhushan R, Fauler B, Lehrach H, Adjaye J. FGF inhibition directs BMP4-mediated differentiation of human embryonic stem cells to syncytiotrophoblast. Stem Cells Dev. 2012;21(16):2987-3000.
69. Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al. Embryonic stem cell lines derived from human blastocysts. Science. 1998;282(5391):1145-7.
70. Tropel P, Tournois J, Côme J, et al. High-efficiency derivation of human embryonic stem cell lines following pre-implantation genetic diagnosis In Vitro. Cell Dev Biol-Animal. 2010;46:376-85.
71. Vaajasaari H, Ilmarinen T, Juuti-Uusitalo K, et al. Toward the defined and xeno-free differentiation of functional human pluripotent stem cell-derived retinal pigment epithelial cells. Mol Vis. 2011;17:558-75.
72. Vallier L, Touboul T, Chng Z, Brimpari M, Hannan N, et al. Early cell fate decisions of human embryonic stem cells and mouse epiblast stem cells are controlled by the same signalling pathways. PLoS One. 2009;4(6):e6082. doi: 10.1371/journal.pone.0006082.
73. Van der Jeught M, O'Leary T, Ghimire S, Lierman S, Duggal G, Versieren K, et al. The combination of inhibitors of FGF/MEK/Erk and GSK3β signaling increases the Number of OCT3/4- and NANOG-positive cells in the human inner cell mass, but does not improve stem cell derivation. Stem Cells Dev. 2012. ahead of print. doi: 10.1089/scd.2012.0256.
74. Villa-Diaz LG, Nandivada H, Ding J, et al. Synthetic polymer coatings for long-term growth of human embryonic stem cells. Nat Biotechnology. 2010;28(6):581-3.
75. Willerth S, Schaffer D. Scaffold materials for hES cell culture and differentiation. In: Ducheyne P, Healy KE, Hutmacher DW, Grainger DW, Kirkpatrick CJ (eds.) Comprehensive Biomaterials (Vol. 5) Elsevier. 2011. p. 95-113.
76. Xu RH, Peck RM, Li DS, Feng X, Ludwig T, Thomson JA. Basic FGF and suppression of BMP signaling sustain undifferentiated proliferation of human ES cells. Nat Methods. 2005;2(3):185-90.
77. Yao S, Chen S, Clark J, et al. Long-term self-renewal and directed differentiation of human embryonic stem cells in chemically defined conditions. PNAS. 2006;103(18):6907-12.
78. Yap LY, Li J, Phang IY, Ong LT, Ow JZ, Goh JC, et al. Defining a threshold surface density of vitronectin for the stable expansion of human embryonic stem cells. Tissue Eng Part C Methods. 2011;17(2):193-207.
79. Zhang X, Stojkovic P, Przyborski S, et al. Derivation of human embryonic stem cells from developing and arrested embryos. Stem Cells. 2006;24:2669-76.
80. Zhou J, Ou-Yang Q, Li J, Zhou X-Y, Lin G, Lu G-X. Human feeder cells support establishment and definitive endoderm differentiation of human embryonic stem cells. Stem Cells Dev. 2008;17:737-50.